Ятрогения в практике интерниста - Журнал Терапевтический архив №1 Поликлинические проблемы и организация медицинской помощи 2019
Ятрогения в практике интерниста
Дворецкий Л.И. Ятрогения в практике интерниста. Терапевтический архив. 2019; 91 (1): 16–128. DOI: 10.26442/00403660.2019.01.000041
DOI: 10.26442/00403660.2019.01.000041
________________________________________________
DOI: 10.26442/00403660.2019.01.000041
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В статье представлена история вопроса, понятие ятрогении, возможные негативные последствия взаимодействия врача и пациента в современных условиях. Приводятся основные формы ятрогений (психогенные, госпитальные, ятрогении диагностических процедур, лекарственные и др.). Важное место занимают имплантационные ятрогении (больные с искусственными клапанами сердца, кардиоимплантированными электронными устройствами, коронарными стентами, суставными эндопротезами). Наиболее уязвимыми в отношении развития ятрогений являются больные пожилого и старческого возраста. Подчеркивается междисциплинарность проблемы ятрогении и ее образовательное значение для терапевтов, врачей общей практики, клинических фармакологов, патологоанатомов и др.
Ключевые слова: ятрогения, ятрогенные события, нежелательные лекарственные реакции, врачебная ошибка.
Keywords: iatrogeniа, iatrogenic events, undesirable drug reactions, мedical error.
Ключевые слова: ятрогения, ятрогенные события, нежелательные лекарственные реакции, врачебная ошибка.
________________________________________________
Keywords: iatrogeniа, iatrogenic events, undesirable drug reactions, мedical error.
Список литературы
1. Steel K, Gertman P, Crescenzi C, et al. Iatrogenic illness on a general medical service at a university hospital. Qual Saf Health Care. 2004;13:76-80. doi:10.1136/qshc.2002.003830
2. Накатис Я.А., Малашенко А.В., Гайденко Г.В., Семиголовский Н.Ю. Смерть в стационаре. Вестник Санкт-Петербургского Университета. 2008; Сер. 11, прил. к вып. 1 [Nakatis YA, Malashenko AV, Gajdenko GV, Semigolovskij NYu. Smert' v stacionare. Vestnik Sankt-Peterburgskogo Universiteta. 2008; Ser. 11, pril. k vyp. 1 (In Russ.)].
3. Некачалов В.В. О ятрогенной патологии (по секционным материалам Ленинграда за 1988 г.). Архив патологии. 1990;52(2):14-7 [Nekachalov VV. O yatrogennoj patologii (po sekcionnym materialam Leningrada za 1988 g.). Arhiv patologii. 1990;52(2):14-7 (In Russ.)].
4. Buist M, Jaffray L, Bell E, Hanna L, Weinstein P, Kumar S, Grimmer K. Utilisation of beds on the general medical unit by ‘nonacute medical’ patients: a retrospective study of incidence and cost in two Tasmanian regional medical hospital units. Intern Med J. 2014;44(2):171-7. doi.org/10.1111/imj.12335
5. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4):483-5.
6. Mohammed N, Mahfouz A, Achkar K, Rafie I, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14(3):106-16. doi:10.4103/1995-705X.1 25926
7. Nough H, Eghbal F, Soltani M, Nejafi F, Falahzadeh H, Fazel H, Sheikhvatan M.. Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty. Cardiorenal Med. 2013;3(2):128-35. doi:10.1159/000351981
8. Kohsaka Sh, Miyata H, Ueda I, Maekawa Y, Kawamura A, Fukuda K, Roe M, Rumsfeld J. An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database–Keio interhospital Cardiovascular Studies (JCD-KiCS). Am Heart J. 2015;170(6):1077-85. doi.org/10.1016/j.ahj.2015.09.017
9. Reumkens A, Rondagh E, Bakker C, Winkens B, Masclee A, Sanduleanu S. Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol. 2016; Aug;111(8):1092-101. doi: 10.1038/ajg.2016.234. Epub 2016 Jun 14
10. Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A, Terzoudis S Pilpilidis I, Zavos C, Kountouras J Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27(1):65-72. doi:10.1038/ajg.2016.234
11. Mond H, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008:31(9):1202-12. doi:10.1111/j.1540-8159.2008.01164.x
12. Friedman D, Parzynski C, Varosy P, Prutkin J, Patton K, Mithani A, Russo A, Curtis J, Al‐Khatib S. Trends and in‐hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1:900-11.
13. Koneru J, Jones P, Hammill E, Wold N, Ellenbogen K. Risk Factors and Temporal Trends of сomplications Associated With Transvenous Implantable Cardiac Defibrillator Leads. J Am Heart Assoc. 2018;7(10)pii:e007691. doi: 10.1161/JAHA.117.007691
14. Grewal S, Chamarthy M, Kalva S Complications of inferior vena cava filters. Cardiovasc Diagn Ther. 2016;6(6):632-41. doi:10.21037/cdt.2016.09.08
15. Nwachukwu B, Bozic K, Schairer W, Bernstein J, Jevsevar D, Marx R, Padgett D. Current status of cost utility analyses in total joint arthroplasty: a systematic review. Clin Orthop Relat Res. 2015;473(5):1815-27. doi: 10.1007/s11999-014-3964-4
16. Gjertsen J, Fenstad A, Leonardsson O, Engesæter L, Kärrholm J, Furnes O, Garellick G, Rogmark C. Hemiarthroplasties after hip fractures in Norway and Sweden: a collaboration between the Norwegian and Swedish national registries. Hip Int. 2014;24(3):223-30. doi: 10.5301/hipint.5000105
17. Legout L, Senneville E. Periprosthetic Joint Infections: Clinical and Bench Research. Sci World J. 2013;16:549091. doi: 10.1155/2013/549091
18. Verberne S, Sonnega R, Temmerman O, Raijmakers P. What is the Accuracy of Nuclear Imaging in the Assessment of Periprosthetic Knee Infection? A Meta-analysis. Clin Orthop Relat Res. 2017;475(5):1395-410. doi:10.1007/s11999-016-5218-0
19. Бегг Э. Клиническая фармакология. М.: Бином. Лаборатория знаний. 2010 [Begg E. Klinicheskaya farmakologiya. M.: Binom. Laboratoriya znanij. 2010 (In Russ.)].
20. Shehab N, Lovegrove M , Geller A, Rose K, Weidle N, Budnitz D. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016;316(20):2115-25. doi: 10.1001/jama.2016.16201
21. Varallo F, Capucho H, Planeta S, Mastroianni P, Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69(3):163-7. doi.org/10.6061/clinics/2014(03)03
22. Alhawassi T, Krass I, Bajorek B, Pont L. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging. 2014;9:2079-86.
23. Díaz Hernández SH, Cruz-Gonzalez I. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients. Consult Pharm. 2018;33(8):454-66. doi: 10.4140/TCP.n.2018.454
24. Beers M, Ouslander J, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med. 1991;151:1825-32.
25. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Clin Pharmacol Ther. 2008;46(2):72-83.
26. O’Mahony D, O’Sullivan D, Byrne S. O'Connor M, Ryan C, Gallagher P STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-8. doi: 10.1093/ageing/afu 145
27. Tosato M, Landi F, Martone А, Cherubini A, Corsonello A, Volpato S, Bernabei R, Onder G. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43(6):767-73. doi: 10.1093/ageing/afu029
28. Данилина К.С., Сычев Д.А., Головина О.В., Ильина Е.С., Горботенкова С.В. Частота назначения потенциально не рекомендованных лекарственных препаратов (по критериям "STOPP START") пожилым пациентам, находящимся в терапевтических отделениях стационара: результаты фармакоэпидемиологического исследования. Фарматека. 2015;13:25-8 [Danilina KS, Syichev DA, Golovina OV, Ilina ES, Gorbotenkova SV. Chastota naznacheniya potentsialno ne rekomendovannyih lekarstvennyih preparatov (po kriteriyam ‟STOPP START‟) pojilyim patsientam, nahodyaschimsya v terapevticheskih otdeleniyah statsionara: rezultatyi farmakoepidemiologicheskogo issledovaniya. Farmateka. 2015;13:25-8 (In Russ.)].
2. Nakatis YA, Malashenko AV, Gajdenko GV, Semigolovskij NYu. Smert' v stacionare. Vestnik Sankt-Peterburgskogo Universiteta. 2008; Ser. 11, pril. k vyp. 1 (In Russ.)
3. Nekachalov VV. O yatrogennoj patologii (po sekcionnym materialam Leningrada za 1988 g.). Arhiv patologii. 1990;52(2):14-7 (In Russ.)
4. Buist M, Jaffray L, Bell E, Hanna L, Weinstein P, Kumar S, Grimmer K. Utilisation of beds on the general medical unit by ‘nonacute medical’ patients: a retrospective study of incidence and cost in two Tasmanian regional medical hospital units. Intern Med J. 2014;44(2):171-7. doi.org/10.1111/imj.12335
5. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4):483-5.
6. Mohammed N, Mahfouz A, Achkar K, Rafie I, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14(3):106-16. doi:10.4103/1995-705X.1 25926
7. Nough H, Eghbal F, Soltani M, Nejafi F, Falahzadeh H, Fazel H, Sheikhvatan M.. Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty. Cardiorenal Med. 2013;3(2):128-35. doi:10.1159/000351981
8. Kohsaka Sh, Miyata H, Ueda I, Maekawa Y, Kawamura A, Fukuda K, Roe M, Rumsfeld J. An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database–Keio interhospital Cardiovascular Studies (JCD-KiCS). Am Heart J. 2015;170(6):1077-85. doi.org/10.1016/j.ahj.2015.09.017
9. Reumkens A, Rondagh E, Bakker C, Winkens B, Masclee A, Sanduleanu S. Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol. 2016; Aug;111(8):1092-101. doi: 10.1038/ajg.2016.234. Epub 2016 Jun 14
10. Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A, Terzoudis S Pilpilidis I, Zavos C, Kountouras J Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27(1):65-72. doi:10.1038/ajg.2016.234
11. Mond H, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008:31(9):1202-12. doi:10.1111/j.1540-8159.2008.01164.x
12. Friedman D, Parzynski C, Varosy P, Prutkin J, Patton K, Mithani A, Russo A, Curtis J, Al‐Khatib S. Trends and in‐hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1:900-11.
13. Koneru J, Jones P, Hammill E, Wold N, Ellenbogen K. Risk Factors and Temporal Trends of сomplications Associated With Transvenous Implantable Cardiac Defibrillator Leads. J Am Heart Assoc. 2018;7(10)pii:e007691. doi: 10.1161/JAHA.117.007691
14. Grewal S, Chamarthy M, Kalva S Complications of inferior vena cava filters. Cardiovasc Diagn Ther. 2016;6(6):632-41. doi:10.21037/cdt.2016.09.08
15. Nwachukwu B, Bozic K, Schairer W, Bernstein J, Jevsevar D, Marx R, Padgett D. Current status of cost utility analyses in total joint arthroplasty: a systematic review. Clin Orthop Relat Res. 2015;473(5):1815-27. doi: 10.1007/s11999-014-3964-4
16. Gjertsen J, Fenstad A, Leonardsson O, Engesæter L, Kärrholm J, Furnes O, Garellick G, Rogmark C. Hemiarthroplasties after hip fractures in Norway and Sweden: a collaboration between the Norwegian and Swedish national registries. Hip Int. 2014;24(3):223-30. doi: 10.5301/hipint.5000105
17. Legout L, Senneville E. Periprosthetic Joint Infections: Clinical and Bench Research. Sci World J. 2013;16:549091. doi: 10.1155/2013/549091
18. Verberne S, Sonnega R, Temmerman O, Raijmakers P. What is the Accuracy of Nuclear Imaging in the Assessment of Periprosthetic Knee Infection? A Meta-analysis. Clin Orthop Relat Res. 2017;475(5):1395-410. doi:10.1007/s11999-016-5218-0
19. Begg E. Klinicheskaya farmakologiya. M.: Binom. Laboratoriya znanij. 2010 (In Russ.)
20. Shehab N, Lovegrove M , Geller A, Rose K, Weidle N, Budnitz D. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016;316(20):2115-25. doi: 10.1001/jama.2016.16201
21. Varallo F, Capucho H, Planeta S, Mastroianni P, Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69(3):163-7. doi.org/10.6061/clinics/2014(03)03
22. Alhawassi T, Krass I, Bajorek B, Pont L. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging. 2014;9:2079-86.
23. Díaz Hernández SH, Cruz-Gonzalez I. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients. Consult Pharm. 2018;33(8):454-66. doi: 10.4140/TCP.n.2018.454
24. Beers M, Ouslander J, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med. 1991;151:1825-32.
25. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Clin Pharmacol Ther. 2008;46(2):72-83.
26. O’Mahony D, O’Sullivan D, Byrne S. O'Connor M, Ryan C, Gallagher P STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-8. doi: 10.1093/ageing/afu 145
27. Tosato M, Landi F, Martone А, Cherubini A, Corsonello A, Volpato S, Bernabei R, Onder G. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43(6):767-73. doi: 10.1093/ageing/afu029
28. Danilina KS, Syichev DA, Golovina OV, Ilina ES, Gorbotenkova SV. Chastota naznacheniya potentsialno ne rekomendovannyih lekarstvennyih preparatov (po kriteriyam ‟STOPP START‟) pojilyim patsientam, nahodyaschimsya v terapevticheskih otdeleniyah statsionara: rezultatyi farmakoepidemiologicheskogo issledovaniya. Farmateka. 2015;13:25-8 (In Russ.)
2. Накатис Я.А., Малашенко А.В., Гайденко Г.В., Семиголовский Н.Ю. Смерть в стационаре. Вестник Санкт-Петербургского Университета. 2008; Сер. 11, прил. к вып. 1 [Nakatis YA, Malashenko AV, Gajdenko GV, Semigolovskij NYu. Smert' v stacionare. Vestnik Sankt-Peterburgskogo Universiteta. 2008; Ser. 11, pril. k vyp. 1 (In Russ.)].
3. Некачалов В.В. О ятрогенной патологии (по секционным материалам Ленинграда за 1988 г.). Архив патологии. 1990;52(2):14-7 [Nekachalov VV. O yatrogennoj patologii (po sekcionnym materialam Leningrada za 1988 g.). Arhiv patologii. 1990;52(2):14-7 (In Russ.)].
4. Buist M, Jaffray L, Bell E, Hanna L, Weinstein P, Kumar S, Grimmer K. Utilisation of beds on the general medical unit by ‘nonacute medical’ patients: a retrospective study of incidence and cost in two Tasmanian regional medical hospital units. Intern Med J. 2014;44(2):171-7. doi.org/10.1111/imj.12335
5. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4):483-5.
6. Mohammed N, Mahfouz A, Achkar K, Rafie I, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14(3):106-16. doi:10.4103/1995-705X.1 25926
7. Nough H, Eghbal F, Soltani M, Nejafi F, Falahzadeh H, Fazel H, Sheikhvatan M.. Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty. Cardiorenal Med. 2013;3(2):128-35. doi:10.1159/000351981
8. Kohsaka Sh, Miyata H, Ueda I, Maekawa Y, Kawamura A, Fukuda K, Roe M, Rumsfeld J. An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database–Keio interhospital Cardiovascular Studies (JCD-KiCS). Am Heart J. 2015;170(6):1077-85. doi.org/10.1016/j.ahj.2015.09.017
9. Reumkens A, Rondagh E, Bakker C, Winkens B, Masclee A, Sanduleanu S. Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol. 2016; Aug;111(8):1092-101. doi: 10.1038/ajg.2016.234. Epub 2016 Jun 14
10. Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A, Terzoudis S Pilpilidis I, Zavos C, Kountouras J Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27(1):65-72. doi:10.1038/ajg.2016.234
11. Mond H, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008:31(9):1202-12. doi:10.1111/j.1540-8159.2008.01164.x
12. Friedman D, Parzynski C, Varosy P, Prutkin J, Patton K, Mithani A, Russo A, Curtis J, Al‐Khatib S. Trends and in‐hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1:900-11.
13. Koneru J, Jones P, Hammill E, Wold N, Ellenbogen K. Risk Factors and Temporal Trends of сomplications Associated With Transvenous Implantable Cardiac Defibrillator Leads. J Am Heart Assoc. 2018;7(10)pii:e007691. doi: 10.1161/JAHA.117.007691
14. Grewal S, Chamarthy M, Kalva S Complications of inferior vena cava filters. Cardiovasc Diagn Ther. 2016;6(6):632-41. doi:10.21037/cdt.2016.09.08
15. Nwachukwu B, Bozic K, Schairer W, Bernstein J, Jevsevar D, Marx R, Padgett D. Current status of cost utility analyses in total joint arthroplasty: a systematic review. Clin Orthop Relat Res. 2015;473(5):1815-27. doi: 10.1007/s11999-014-3964-4
16. Gjertsen J, Fenstad A, Leonardsson O, Engesæter L, Kärrholm J, Furnes O, Garellick G, Rogmark C. Hemiarthroplasties after hip fractures in Norway and Sweden: a collaboration between the Norwegian and Swedish national registries. Hip Int. 2014;24(3):223-30. doi: 10.5301/hipint.5000105
17. Legout L, Senneville E. Periprosthetic Joint Infections: Clinical and Bench Research. Sci World J. 2013;16:549091. doi: 10.1155/2013/549091
18. Verberne S, Sonnega R, Temmerman O, Raijmakers P. What is the Accuracy of Nuclear Imaging in the Assessment of Periprosthetic Knee Infection? A Meta-analysis. Clin Orthop Relat Res. 2017;475(5):1395-410. doi:10.1007/s11999-016-5218-0
19. Бегг Э. Клиническая фармакология. М.: Бином. Лаборатория знаний. 2010 [Begg E. Klinicheskaya farmakologiya. M.: Binom. Laboratoriya znanij. 2010 (In Russ.)].
20. Shehab N, Lovegrove M , Geller A, Rose K, Weidle N, Budnitz D. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016;316(20):2115-25. doi: 10.1001/jama.2016.16201
21. Varallo F, Capucho H, Planeta S, Mastroianni P, Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69(3):163-7. doi.org/10.6061/clinics/2014(03)03
22. Alhawassi T, Krass I, Bajorek B, Pont L. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging. 2014;9:2079-86.
23. Díaz Hernández SH, Cruz-Gonzalez I. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients. Consult Pharm. 2018;33(8):454-66. doi: 10.4140/TCP.n.2018.454
24. Beers M, Ouslander J, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med. 1991;151:1825-32.
25. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Clin Pharmacol Ther. 2008;46(2):72-83.
26. O’Mahony D, O’Sullivan D, Byrne S. O'Connor M, Ryan C, Gallagher P STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-8. doi: 10.1093/ageing/afu 145
27. Tosato M, Landi F, Martone А, Cherubini A, Corsonello A, Volpato S, Bernabei R, Onder G. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43(6):767-73. doi: 10.1093/ageing/afu029
28. Данилина К.С., Сычев Д.А., Головина О.В., Ильина Е.С., Горботенкова С.В. Частота назначения потенциально не рекомендованных лекарственных препаратов (по критериям "STOPP START") пожилым пациентам, находящимся в терапевтических отделениях стационара: результаты фармакоэпидемиологического исследования. Фарматека. 2015;13:25-8 [Danilina KS, Syichev DA, Golovina OV, Ilina ES, Gorbotenkova SV. Chastota naznacheniya potentsialno ne rekomendovannyih lekarstvennyih preparatov (po kriteriyam ‟STOPP START‟) pojilyim patsientam, nahodyaschimsya v terapevticheskih otdeleniyah statsionara: rezultatyi farmakoepidemiologicheskogo issledovaniya. Farmateka. 2015;13:25-8 (In Russ.)].
________________________________________________
2. Nakatis YA, Malashenko AV, Gajdenko GV, Semigolovskij NYu. Smert' v stacionare. Vestnik Sankt-Peterburgskogo Universiteta. 2008; Ser. 11, pril. k vyp. 1 (In Russ.)
3. Nekachalov VV. O yatrogennoj patologii (po sekcionnym materialam Leningrada za 1988 g.). Arhiv patologii. 1990;52(2):14-7 (In Russ.)
4. Buist M, Jaffray L, Bell E, Hanna L, Weinstein P, Kumar S, Grimmer K. Utilisation of beds on the general medical unit by ‘nonacute medical’ patients: a retrospective study of incidence and cost in two Tasmanian regional medical hospital units. Intern Med J. 2014;44(2):171-7. doi.org/10.1111/imj.12335
5. Starfield B. Is US health really the best in the world? JAMA. 2000; 284(4):483-5.
6. Mohammed N, Mahfouz A, Achkar K, Rafie I, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14(3):106-16. doi:10.4103/1995-705X.1 25926
7. Nough H, Eghbal F, Soltani M, Nejafi F, Falahzadeh H, Fazel H, Sheikhvatan M.. Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty. Cardiorenal Med. 2013;3(2):128-35. doi:10.1159/000351981
8. Kohsaka Sh, Miyata H, Ueda I, Maekawa Y, Kawamura A, Fukuda K, Roe M, Rumsfeld J. An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database–Keio interhospital Cardiovascular Studies (JCD-KiCS). Am Heart J. 2015;170(6):1077-85. doi.org/10.1016/j.ahj.2015.09.017
9. Reumkens A, Rondagh E, Bakker C, Winkens B, Masclee A, Sanduleanu S. Post-Colonoscopy Complications: A Systematic Review, Time Trends, and Meta-Analysis of Population-Based Studies. Am J Gastroenterol. 2016; Aug;111(8):1092-101. doi: 10.1038/ajg.2016.234. Epub 2016 Jun 14
10. Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A, Terzoudis S Pilpilidis I, Zavos C, Kountouras J Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27(1):65-72. doi:10.1038/ajg.2016.234
11. Mond H, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008:31(9):1202-12. doi:10.1111/j.1540-8159.2008.01164.x
12. Friedman D, Parzynski C, Varosy P, Prutkin J, Patton K, Mithani A, Russo A, Curtis J, Al‐Khatib S. Trends and in‐hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1:900-11.
13. Koneru J, Jones P, Hammill E, Wold N, Ellenbogen K. Risk Factors and Temporal Trends of сomplications Associated With Transvenous Implantable Cardiac Defibrillator Leads. J Am Heart Assoc. 2018;7(10)pii:e007691. doi: 10.1161/JAHA.117.007691
14. Grewal S, Chamarthy M, Kalva S Complications of inferior vena cava filters. Cardiovasc Diagn Ther. 2016;6(6):632-41. doi:10.21037/cdt.2016.09.08
15. Nwachukwu B, Bozic K, Schairer W, Bernstein J, Jevsevar D, Marx R, Padgett D. Current status of cost utility analyses in total joint arthroplasty: a systematic review. Clin Orthop Relat Res. 2015;473(5):1815-27. doi: 10.1007/s11999-014-3964-4
16. Gjertsen J, Fenstad A, Leonardsson O, Engesæter L, Kärrholm J, Furnes O, Garellick G, Rogmark C. Hemiarthroplasties after hip fractures in Norway and Sweden: a collaboration between the Norwegian and Swedish national registries. Hip Int. 2014;24(3):223-30. doi: 10.5301/hipint.5000105
17. Legout L, Senneville E. Periprosthetic Joint Infections: Clinical and Bench Research. Sci World J. 2013;16:549091. doi: 10.1155/2013/549091
18. Verberne S, Sonnega R, Temmerman O, Raijmakers P. What is the Accuracy of Nuclear Imaging in the Assessment of Periprosthetic Knee Infection? A Meta-analysis. Clin Orthop Relat Res. 2017;475(5):1395-410. doi:10.1007/s11999-016-5218-0
19. Begg E. Klinicheskaya farmakologiya. M.: Binom. Laboratoriya znanij. 2010 (In Russ.)
20. Shehab N, Lovegrove M , Geller A, Rose K, Weidle N, Budnitz D. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA. 2016;316(20):2115-25. doi: 10.1001/jama.2016.16201
21. Varallo F, Capucho H, Planeta S, Mastroianni P, Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69(3):163-7. doi.org/10.6061/clinics/2014(03)03
22. Alhawassi T, Krass I, Bajorek B, Pont L. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging. 2014;9:2079-86.
23. Díaz Hernández SH, Cruz-Gonzalez I. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients. Consult Pharm. 2018;33(8):454-66. doi: 10.4140/TCP.n.2018.454
24. Beers M, Ouslander J, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med. 1991;151:1825-32.
25. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Clin Pharmacol Ther. 2008;46(2):72-83.
26. O’Mahony D, O’Sullivan D, Byrne S. O'Connor M, Ryan C, Gallagher P STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-8. doi: 10.1093/ageing/afu 145
27. Tosato M, Landi F, Martone А, Cherubini A, Corsonello A, Volpato S, Bernabei R, Onder G. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43(6):767-73. doi: 10.1093/ageing/afu029
28. Danilina KS, Syichev DA, Golovina OV, Ilina ES, Gorbotenkova SV. Chastota naznacheniya potentsialno ne rekomendovannyih lekarstvennyih preparatov (po kriteriyam ‟STOPP START‟) pojilyim patsientam, nahodyaschimsya v terapevticheskih otdeleniyah statsionara: rezultatyi farmakoepidemiologicheskogo issledovaniya. Farmateka. 2015;13:25-8 (In Russ.)
Авторы
Л.И. Дворецкий
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
________________________________________________
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.